Action VELO VELOXIS PHARMACEUTICALS A/S
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Veloxis Pharmaceuticals A/S

Actions

VELO

DK0060048148

Temps Différé Nasdaq Copenhagen
Autres places de cotation
 		Varia. 5j. Varia. 1 janv.
- DKK -.--% Graphique intraday de Veloxis Pharmaceuticals A/S -.--% -0,50 %
30/05 Veloxis Pharmaceuticals A/S choisit de présenter ses travaux au 2024 American Transplant Congress à Philadelphie CI
2022 Veloxis Pharmaceuticals annonce le dosage du premier patient par son partenaire Xenikos dans l'étude mondiale de phase 3 évaluant T-Guard(R) chez les patients atteints de la maladie aiguë du greffon contre l'hôte réfractaire aux stéroïdes (SR-aGVHD) CI

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Scandion Oncology A/S : appoints Johnny Stilou as new CFO
AQ
Veloxis Pharmaceuticals A/S : Extraordinary General Meeting of Veloxis Pharmaceuticals A/S, 17 February 2020
AQ
Veloxis Pharmaceuticals A/S : Nasdaq Copenhagen A/S has Accepted Veloxis Pharmaceuticals A/S' Request for Delisting of its Shares from Nasdaq Copenhagen A/S
AQ
Veloxis Pharmaceuticals A/S : - Notice to Convene Extraordinary General Meeting
AQ
Veloxis Pharmaceuticals A/S : Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S
AQ
Veloxis Pharmaceuticals A/S : - Major Shareholder Notifications
AQ
Veloxis Pharmaceuticals A/S : Notice to Convene Extraordinary General Meeting
AQ
Veloxis Pharmaceuticals A/S : Announcement of Request for Delisting of Veloxis Pharmaceuticals A/S' Shares from Nasdaq Copenhagen
AQ
Veloxis Pharmaceuticals A/S : Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S
AQ
Veloxis Pharmaceuticals A/S: Major Shareholder Notifications
AQ
Veloxis Pharmaceuticals A/S : Increases Share Capital in Connection with Asahi Kasei Pharma Denmark's Exercise of Warrants Acquired under the Public Tender Offer
AQ
Veloxis Pharmaceuticals A/S : Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer
AQ
Veloxis Pharmaceuticals A/S : Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer
AQ
Veloxis Pharmaceuticals A/S : - Reporting of Managers and Closely Associated Persons Transactions in Veloxis-Shares and Financial Instruments Linked Hereto
AQ
Veloxis Pharmaceuticals A/S : - Major Shareholder Notifications
AQ
Veloxis Pharmaceuticals A/S : - Asahi Kasei Pharma Denmark Announces the Preliminary Result and Completion of its Public Tender Offer for the Shares and Warrants
AQ
Veloxis Pharmaceuticals: Reporting of Managers' and Closely Associated Persons' Transactions in Veloxis-Shares and Financial Instruments Linked Hereto
AQ
Veloxis Pharmaceuticals: Major Shareholder Notifications
AQ
Veloxis Pharmaceuticals: Asahi Kasei Pharma Denmark Announces the Preliminary Result and Completion of its Public Tender Offer for the Shares and Warrants in Veloxis Pharmaceuticals
AQ
Veloxis Pharmaceuticals A/S : - Reminder of the deadline for acceptance of Asahi Kasei Pharma Denmark's public takeover offer
AQ
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action VELO
  4. Actualités Veloxis Pharmaceuticals A/S
  5. Communiqués